Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 117 articles:
HTML format
Text format



Single Articles


    March 2017
  1. MCSORLEY ST, Roxburgh CS, Horgan PG, McMillan DC, et al
    The Impact of Preoperative Dexamethasone on the Magnitude of the Postoperative Systemic Inflammatory Response and Complications Following Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2017 Mar 1. doi: 10.1245/s10434-017-5817.
    PubMed     Text format     Abstract available


    February 2017
  2. ALI SM, Pawlik TM, Rodriguez-Bigas MA, Monson JR, et al
    Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-016-5745.
    PubMed     Text format     Abstract available


  3. CAVNAR MJ, Turcotte S, Katz SC, Kuk D, et al
    Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.
    Ann Surg Oncol. 2017 Feb 17. doi: 10.1245/s10434-017-5812.
    PubMed     Text format     Abstract available


    January 2017
  4. ALOTAIBI AM, Lee JL, Kim J, Lim SB, et al
    Prognostic and Oncologic Significance of Perineural Invasion in Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2017 Jan 9. doi: 10.1245/s10434-016-5748.
    PubMed     Text format     Abstract available


    December 2016
  5. XIE D, Yu C, Gao C, Osaiweran H, et al
    An Optimal Approach for Laparoscopic D3 Lymphadenectomy Plus Complete Mesocolic Excision (D3+CME) for Right-Sided Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  6. NAGATA H, Ishihara S, Hata K, Murono K, et al
    Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  7. KIM JE, Hong YS, Kim HJ, Kim KP, et al
    Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  8. KITAHARA T, Haraguchi N, Takahashi H, Nishimura J, et al
    Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  9. WATT DG, McSorley ST, Park JH, Horgan PG, et al
    A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  10. LISKA D, Stocchi L, Karagkounis G, Elagili F, et al
    Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  11. KIM TJ, Kim ER, Hong SN, Kim YH, et al
    Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  12. BECERRA AZ, Aquina CT, Mohile SG, Tejani MA, et al
    Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  13. VAN DE GRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Erratum to: Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  14. KIM CG, Ahn JB, Jung M, Beom SH, et al
    Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  15. VAN DEGRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  16. NAVEZ J, Remue C, Leonard D, Bachmann R, et al
    Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  17. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  18. CIENFUEGOS JA, Martinez P, Baixauli J, Beorlegui C, et al
    Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  19. BECERRA AZ, Berho ME, Probst CP, Aquina CT, et al
    Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  20. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  21. BARATTI D, Kusamura S, Iusco D, Gimondi S, et al
    Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  22. TAN CN, Chong CS, Fong YF, Rauff S, et al
    Laparoscopic Anterior Resection with Transvaginal Specimen Extraction (TVSE) for Colorectal Cancer and Concomitant Total Hysterectomy and Bilateral Salpingo-Oophrectomy (THBSO): A Technical Description.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  23. NISHIZAWA Y, Nishida N, Konno M, Kawamoto K, et al
    Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  24. DURAES LC, Stocchi L, Dietz D, Kalady MF, et al
    The Disproportionate Effect of Perioperative Complications on Mortality within 1 Year After Colorectal Cancer Resection in Octogenarians.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  25. KARANICOLAS PJ, Ko YJ
    Hepatic Arterial Infusion for Unresectable Liver Metastases from Colorectal Cancer: The Dawn of a New Era?
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  26. LAO X, Feng Q, He G, Ji M, et al
    Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  27. AMRI R, England J, Bordeianou LG, Berger DL, et al
    Risk Stratification in Patients with Stage II Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  28. YAMAMOTO H, Maeda K, Arima H, Sonoda H, et al
    Perioperative Adiponectin Measurement is Useful for Prediction of Postoperative Infection in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  29. CHEMAMA S, Bayar MA, Lanoy E, Ammari S, et al
    Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  30. SHIDA D, Hamaguchi T, Ochiai H, Tsukamoto S, et al
    Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  31. SUGIMACHI K, Matsumura T, Shimamura T, Hirata H, et al
    Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  32. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  33. LIM C, Doussot A, Osseis M, Salloum C, et al
    Primary Tumor Versus Liver-First Strategy in Patients with Stage IVA Colorectal Cancer: A Propensity Score Analysis of Long-term Outcomes and Recurrence Pattern.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  34. TARANTINO I, Huttner FJ, Warschkow R, Schmied BM, et al
    Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
    Ann Surg Oncol. 2016;23:1576-86.
    PubMed     Text format     Abstract available


  35. COLOMBO PE, Bertrand MM, Alline M, Boulay E, et al
    Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? : A Single-Center Series of 120 Consecutive Patients.
    Ann Surg Oncol. 2016;23:1594-600.
    PubMed     Text format     Abstract available


    April 2016
  36. BREUGOM AJ, van Dongen DT, Bastiaannet E, Dekker FW, et al
    Association Between the Most Frequent Complications After Surgery for Stage I-III Colon Cancer and Short-Term Survival, Long-Term Survival, and Recurrences.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  37. MALKOMES P, Lunger I, Luetticke A, Oppermann E, et al
    Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  38. WEI AC, Coburn NG, Devitt KS, Serrano PE, et al
    Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  39. SIMKENS GA, van Oudheusden TR, Nieboer D, Steyerberg EW, et al
    Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  40. MCSORLEY ST, Watt DG, Horgan PG, McMillan DC, et al
    Postoperative Systemic Inflammatory Response, Complication Severity, and Survival Following Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  41. CHIA CS, Tan GH, Lim C, Soo KC, et al
    Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  42. AHMED S, Leis A, Chandra-Kanthan S, Fields A, et al
    Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  43. MALIETZIS G, Currie AC, Johns N, Fearon KC, et al
    Skeletal Muscle Changes After Elective Colorectal Cancer Resection: A Longitudinal Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  44. BAZZARELLI AK, Scheer AS, Tai LH, Seth R, et al
    Tissue Factor Pathway Inhibitor Gene Polymorphism -33T --> C Predicts Improved Disease-Free Survival in Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  45. CHANDHOKE G, Wei X, Nanji S, Biagi J, et al
    Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  46. PARK SY, Choi GS, Park JS, Kim HJ, et al
    Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  47. LEE SJ, Kang BW, Chae YS, Kim HJ, et al
    Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2016;23:894-9.
    PubMed     Text format     Abstract available


  48. ROBINSON C, Artinyan A
    Pushing the Limits of Local Excision for Rectal Cancer: Transanal Minimally Invasive Surgery (TAMIS) for Rectal Cancer Using the Port-in-Port Technique.
    Ann Surg Oncol. 2016;23:918.
    PubMed     Text format     Abstract available


  49. HUNTINGTON CR, Boselli D, Symanowski J, Hill JS, et al
    Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2016;23:877-87.
    PubMed     Text format     Abstract available


  50. ZIMMITTI G, Soliz J, Aloia TA, Gottumukkala V, et al
    Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2016;23:1003-11.
    PubMed     Text format     Abstract available


  51. LUDMIR EB, Arya R, Wu Y, Palta M, et al
    Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.
    Ann Surg Oncol. 2016;23:856-62.
    PubMed     Text format     Abstract available


  52. MAILLET M, Glehen O, Lambert J, Goere D, et al
    Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.
    Ann Surg Oncol. 2016;23:863-9.
    PubMed     Text format     Abstract available


  53. CHANG SC, Lin PC, Lin JK, Lin CH, et al
    Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Ann Surg Oncol. 2016;23:849-55.
    PubMed     Text format     Abstract available


  54. LEOWARDI C, Schneider ML, Hinz U, Harnoss JM, et al
    Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Ann Surg Oncol. 2016;23:870-6.
    PubMed     Text format     Abstract available


  55. SIMKENS GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, et al
    Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2016;23:833-41.
    PubMed     Text format     Abstract available


    February 2016
  56. MOKUTANI Y, Uemura M, Munakata K, Okuzaki D, et al
    Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  57. MUKAI S, Oue N, Oshima T, Mukai R, et al
    Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  58. MATSUMOTO Y, Tsujimoto H, Ono S, Shinomiya N, et al
    Abdominal Infection Suppresses the Number and Activity of Intrahepatic Natural Killer Cells and Promotes Tumor Growth in a Murine Liver Metastasis Model.
    Ann Surg Oncol. 2016;23 Suppl 2:S257-65.
    PubMed     Text format     Abstract available


  59. MAEDA Y, Shinohara T, Nagatsu A, Futakawa N, et al
    Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2016;23 Suppl 2:S242-8.
    PubMed     Text format     Abstract available


  60. KOYAMA M, Murata A, Sakamoto Y, Morohashi H, et al
    Risk Factors for Anastomotic Leakage After Intersphincteric Resection Without a Protective Defunctioning Stoma for Lower Rectal Cancer.
    Ann Surg Oncol. 2016;23 Suppl 2:S249-56.
    PubMed     Text format     Abstract available


  61. KENG C, Coates A, Grubac V, Lovrics P, et al
    The Need for Consensus and Transparency in Assessing Population-Based Rates of Positive Circumferential Radial Margins in Rectal Cancer: Data from Consecutive Cases in a Large Region of Ontario, Canada.
    Ann Surg Oncol. 2016;23:397-402.
    PubMed     Text format     Abstract available


  62. YAMAMOTO H, Tomita N, Inomata M, Furuhata T, et al
    OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan.
    Ann Surg Oncol. 2016;23:391-6.
    PubMed     Text format     Abstract available


  63. TOKUNAGA R, Sakamoto Y, Nakagawa S, Miyake K, et al
    The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer.
    Ann Surg Oncol. 2016;23:678-85.
    PubMed     Text format     Abstract available


  64. DOWNS-CANNER S, Magge D, Ravindranathan R, O'Malley ME, et al
    Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.
    Ann Surg Oncol. 2016;23:655-62.
    PubMed     Text format     Abstract available


  65. NISHIGORI N, Koyama F, Nakagawa T, Nakamura S, et al
    Visualization of Lymph/Blood Flow in Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI).
    Ann Surg Oncol. 2016;23 Suppl 2:S266-74.
    PubMed     Text format     Abstract available


  66. YAMADA T, Okabayashi K, Hasegawa H, Tsuruta M, et al
    Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery.
    Ann Surg Oncol. 2016;23 Suppl 2:S236-41.
    PubMed     Text format     Abstract available


    January 2016
  67. KISHIKAWA J, Kazama S, Oba K, Hasegawa K, et al
    CD133 Expression at the Metastatic Site Predicts Patients' Outcome in Colorectal Cancer with Synchronous Liver Metastasis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  68. KYE BH, Lee YS, Cho HM, Kim JG, et al
    Comparison of Long-Term Outcomes Between Emergency Surgery and Bridge to Surgery for Malignant Obstruction in Right-Sided Colon Cancer: A Multicenter Retrospective Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  69. VERWEIJ NM, Schiphorst AH, Maas HA, Zimmerman DD, et al
    Colorectal Cancer Resections in the Oldest Old Between 2011 and 2012 in The Netherlands.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  70. MASSARWEH NN, Li LT, Sansgiry S, Berger DH, et al
    Primary Tumor Resection and Multimodality Treatment for Patients with Metastatic Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  71. BECERRA AZ, Probst CP, Tejani MA, Aquina CT, et al
    Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  72. DE CUBA EM, de Hingh IH, Sluiter NR, Kwakman R, et al
    Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  73. WEISER MR
    Rectal Cancer: Time for Precision Medicine?
    Ann Surg Oncol. 2016;23:12-5.
    PubMed     Text format    


  74. KULU Y, Tarantino I, Billeter AT, Diener MK, et al
    Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Ann Surg Oncol. 2016;23:106-13.
    PubMed     Text format     Abstract available


  75. SIMKENS GA, van Oudheusden TR, Braam HJ, Luyer MD, et al
    Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
    Ann Surg Oncol. 2016;23:99-105.
    PubMed     Text format     Abstract available


    December 2015
  76. CONNOR AA, McNamara K, Al-Sukhni E, Diskin J, et al
    Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  77. BAE SU, Han YD, Cho MS, Hur H, et al
    Oncologic Outcomes of Colon Cancer Patients with Extraregional Lymph Node Metastasis: Comparison of Isolated Paraaortic Lymph Node Metastasis with Resectable Liver Metastasis.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  78. FRANSGAARD T, Thygesen LC, Gogenur I
    Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  79. CHEN HC, Huang HY, Chen YL, Lee KD, et al
    Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  80. PARK SJ, Lee KY, Kwon SH, Lee SH, et al
    Stenting as a Bridge to Surgery for Obstructive Colon Cancer: Does It Have Surgical Merit or Oncologic Demerit?
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  81. JONES RP, Poston GJ
    Decision Making Around Optimal Management of Liver-Limited Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format    


    November 2015
  82. AMRI R, Bordeianou LG, Berger DL
    Effect of High-Grade Disease on Outcomes of Surgically Treated Colon Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  83. CHEN Y, Yuan R, Wu X, He X, et al
    A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  84. HANYUDA A, Kim SA, Martinez-Fernandez A, Qian ZR, et al
    Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  85. BOOTH CM, Nanji S, Wei X, Mackillop WJ, et al
    Outcomes of Resected Colorectal Cancer Lung Metastases in Routine Clinical Practice: A Population-Based Study.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  86. KASER SA, Mattiello D, Maurer CA
    Distant Metastasis in Colorectal Cancer is a Risk Factor for Anastomotic Leakage.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  87. YOSHIDA N, Kinugasa T, Miyoshi H, Sato K, et al
    A High RORgammaT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  88. CHOTI MA, Thomas M, Wong SL, Eaddy M, et al
    Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  89. ISHIZUKA M, Nagata H, Takagi K, Iwasaki Y, et al
    Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  90. PARK HS, Jung M, Shin SJ, Heo SJ, et al
    Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  91. TEREZAKIS S, Morikawa L, Wu A, Zhang Z, et al
    Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.
    Ann Surg Oncol. 2015;22:2168-78.
    PubMed     Text format     Abstract available


  92. HUANG SC, Lin JK, Lin TC, Chen WS, et al
    Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
    Ann Surg Oncol. 2015;22:2262-8.
    PubMed     Text format     Abstract available


  93. KRELL RW, Reames BN, Hendren S, Frankel TL, et al
    Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey.
    Ann Surg Oncol. 2015;22:2179-94.
    PubMed     Text format     Abstract available


  94. KARAGKOUNIS G, Cai G, Johnson PT, Pawlik TM, et al
    The Role of Neoadjuvant Therapy in Characterizing Indeterminate Lung Lesions in Patients with Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2015;22:2201-8.
    PubMed     Text format     Abstract available


  95. IHN MH, Kim YH, Kim DW, Oh HK, et al
    Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging.
    Ann Surg Oncol. 2015;22:2159-67.
    PubMed     Text format     Abstract available


  96. HELLAN M, Ouellette J, Lagares-Garcia JA, Rauh SM, et al
    Robotic Rectal Cancer Resection: A Retrospective Multicenter Analysis.
    Ann Surg Oncol. 2015;22:2151-8.
    PubMed     Text format     Abstract available


  97. FRANCESCUTTI V, Amin N, Cadeddu M, Eskicioglu C, et al
    An Internet-Based Collaborative Cancer Conference for Rectal Cancer Influenced Surgeon Treatment Recommendations.
    Ann Surg Oncol. 2015;22:2143-50.
    PubMed     Text format     Abstract available


  98. DUELAND S, Hagness M, Line PD, Guren TK, et al
    Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?
    Ann Surg Oncol. 2015;22:2195-200.
    PubMed     Text format     Abstract available


    May 2015
  99. KELLY KJ, Baumgartner JM, Lowy AM
    Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei.
    Ann Surg Oncol. 2015;22:1722-5.
    PubMed     Text format     Abstract available


  100. MISE Y, Kopetz S, Mehran RJ, Aloia TA, et al
    Is complete liver resection without resection of synchronous lung metastases justified?
    Ann Surg Oncol. 2015;22:1585-92.
    PubMed     Text format     Abstract available


  101. TORZILLI G, Procopio F, Cimino M, Donadon M, et al
    Hepatic vein-sparing hepatectomy for multiple colorectal liver metastases at the caval confluence.
    Ann Surg Oncol. 2015;22:1576.
    PubMed     Text format     Abstract available


  102. BAUMGARTNER JM, Tobin L, Heavey SF, Kelly KJ, et al
    Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Ann Surg Oncol. 2015;22:1716-21.
    PubMed     Text format     Abstract available


  103. BARTLETT EK, Choudhury RA, Roses RE, Fraker DL, et al
    Intraperitoneal chemotherapy at the time of surgery is not associated with increased 30-day morbidity and mortality following colorectal resection.
    Ann Surg Oncol. 2015;22:1664-72.
    PubMed     Text format     Abstract available


    April 2015
  104. YOO BE, Cho JS, Shin JW, Lee DW, et al
    Robotic versus laparoscopic intersphincteric resection for low rectal cancer: comparison of the operative, oncological, and functional outcomes.
    Ann Surg Oncol. 2015;22:1219-25.
    PubMed     Text format     Abstract available


  105. INAMURA K, Yamauchi M, Nishihara R, Kim SA, et al
    Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
    Ann Surg Oncol. 2015;22:1226-35.
    PubMed     Text format     Abstract available


  106. STREMITZER S, Stift J, Graf A, Singh J, et al
    CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Ann Surg Oncol. 2015;22:1315-23.
    PubMed     Text format     Abstract available


  107. VAN OUDHEUSDEN TR, Braam HJ, Luyer MD, Wiezer MJ, et al
    Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis.
    Ann Surg Oncol. 2015;22:1236-42.
    PubMed     Text format     Abstract available


  108. SHELAT VG, Cipriani F, Basseres T, Armstrong TH, et al
    Pure laparoscopic liver resection for large malignant tumors: does size matter?
    Ann Surg Oncol. 2015;22:1288-93.
    PubMed     Text format     Abstract available


    January 2015
  109. RATTI F, Schadde E, Masetti M, Massani M, et al
    Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy.
    Ann Surg Oncol. 2015;22:1933-42.
    PubMed     Text format     Abstract available


  110. ALLARD MA, Sebagh M, Baillie G, Lemoine A, et al
    Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
    Ann Surg Oncol. 2015;22:1925-32.
    PubMed     Text format     Abstract available


  111. CUCCHETTI A, Ferrero A, Cescon M, Donadon M, et al
    Cure model survival analysis after hepatic resection for colorectal liver metastases.
    Ann Surg Oncol. 2015;22:1908-14.
    PubMed     Text format     Abstract available


  112. KIM HJ, Jo JS, Lee SY, Kim CH, et al
    Low Lymph Node Retrieval After Preoperative Chemoradiation for Rectal Cancer is Associated with Improved Prognosis in Patients with a Good Tumor Response.
    Ann Surg Oncol. 2015;22:2075-81.
    PubMed     Text format     Abstract available


  113. HABERMEHL D, Wagner M, Ellerbrock M, Buchler MW, et al
    Reirradiation Using Carbon Ions in Patients with Locally Recurrent Rectal Cancer at HIT: First Results.
    Ann Surg Oncol. 2015;22:2068-74.
    PubMed     Text format     Abstract available


  114. KULU Y, Tarantio I, Warschkow R, Kny S, et al
    Anastomotic leakage is associated with impaired overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Ann Surg Oncol. 2015;22:2059-67.
    PubMed     Text format     Abstract available


  115. KULU Y, Muller-Stich BP, Bruckner T, Gehrig T, et al
    Radical surgery with total mesorectal excision in patients with T1 rectal cancer.
    Ann Surg Oncol. 2015;22:2051-8.
    PubMed     Text format     Abstract available


  116. HINOI T, Kawaguchi Y, Hattori M, Okajima M, et al
    Laparoscopic versus open surgery for colorectal cancer in elderly patients: a multicenter matched case-control study.
    Ann Surg Oncol. 2015;22:2040-50.
    PubMed     Text format     Abstract available


  117. SALAH S, Ardissone F, Gonzalez M, Gervaz P, et al
    Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis.
    Ann Surg Oncol. 2015;22:1844-50.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: